Optimal sampling site for mucosal candidosis in oral cancer patients is the labial sulcus

被引:21
作者
Rautemaa, Riina [1 ]
Rusanen, Peter
Richardson, Malcolm
Meurman, Jukka H.
机构
[1] Univ Helsinki, Haartman Inst, Dept Bacteriol & Immunol, Helsinki, Finland
[2] Univ Helsinki, Cent Hosp, Dept Oral & Maxillofacial Dis, Helsinki, Finland
[3] Univ Helsinki, Cent Hosp, Microbiol Unit, Diagnost Lab, Helsinki, Finland
[4] Univ Helsinki, Inst Dent, Helsinki, Finland
关键词
D O I
10.1099/jmm.0.46615-0
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
Traditional sampling methods for the diagnosis of oral candidosis in head and neck cancer patients, i.e. saliva collection or tongue scrapings, are often impossible to perform. The aim was to determine the optimal sampling method. Eighteen oral cancer patients and five control subjects were sampled semi-quantitatively from the labial sulcus, dorsum of the tongue, dental plaque and saliva for cultivation of yeasts. The patients were examined prior to all cancer treatment (n = 5), or 2-4 weeks (n = 5) or 8-12 weeks (n = 8) post-operatively. The incidence of Candida was found to increase from 40 % at the control and pre-operative level up to 73 % 8-12 weeks post-operatively. Candida albicans was found to be the only species until 4 weeks post-operatively. Thereafter, the incidence of species other than C. albicans was 38 %. The most sensitive sampling site was found to be the vestibular sulcus, from which all culture-positive cases could be confirmed. Tongue surface scraping was found to be more sensitive than saliva collection in detecting Candida. All sampling methods and sites were equally sensitive in detecting the different Candida species. Dental plaque was found to have the highest density of Candida colonization, and was thus found to be the most significant source of Candida infection, which emphasizes the role of dental care in these patients.
引用
收藏
页码:1447 / 1451
页数:5
相关论文
共 7 条
[1]   High prevalence of non-albicans yeasts and detection of anti-fungal resistance in the oral flora of patients with advanced cancer [J].
Bagg, J ;
Sweeney, MP ;
Lewis, MAO ;
Coleman, D ;
Al Mosaid, A ;
Baxter, W ;
McEndrick, S ;
McHugh, S .
PALLIATIVE MEDICINE, 2003, 17 (06) :477-481
[2]   Oral Candida isolates in patients undergoing radiotherapy for head and neck cancer:: prevalence, azole susceptibility profiles and response to antifungal treatment [J].
Belazi, M ;
Velegraki, A ;
Koussidou-Eremondi, T ;
Andreadis, D ;
Hini, S ;
Arsenis, G ;
Eliopoulou, C ;
Destouni, E ;
Antoniades, D .
ORAL MICROBIOLOGY AND IMMUNOLOGY, 2004, 19 (06) :347-351
[3]  
Calderone R.A., 2002, CANDIDA CANDIDIASIS
[4]   Candida glabrata is an emerging cause of oropharyngeal candidiasis in patients receiving radiation for head and neck cancer [J].
Redding, SW ;
Dahiya, MC ;
Kirkpatrick, WR ;
Coco, BJ ;
Patterson, TF ;
Fothergill, AW ;
Rinaldi, MG ;
Thomas, CR .
ORAL SURGERY ORAL MEDICINE ORAL PATHOLOGY ORAL RADIOLOGY AND ENDODONTICS, 2004, 97 (01) :47-52
[5]   Epidemiology of oropharyngeal Candida colonization and infection in patients receiving radiation for head and neck cancer [J].
Redding, SW ;
Zellars, RC ;
Kirkpatrick, WR ;
McAtee, RK ;
Caceres, MA ;
Fothergill, AW ;
Lopez-Ribot, JL ;
Bailey, CW ;
Rinaldi, MG ;
Patterson, TF .
JOURNAL OF CLINICAL MICROBIOLOGY, 1999, 37 (12) :3896-3900
[6]  
Richardson M.D., 2003, FUNGAL INFECT DIAGNO, V3rd
[7]   Intensity modulated radiotherapy for head and neck cancer:: evidence for preserved salivary gland function [J].
Saarilahti, K ;
Kouri, M ;
Collan, J ;
Hämäläinen, T ;
Atula, T ;
Joensuu, H ;
Tenhunen, M .
RADIOTHERAPY AND ONCOLOGY, 2005, 74 (03) :251-258